Works by de Bono, Johann S.

Results: 56
    1
    2

    Phase I and pharmacokinetic study of cisplatin and troxacitabine administered intravenously every 28 days in patients with advanced solid malignancies.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2009, v. 65, n. 1, p. 167, doi. 10.1007/s00280-009-1020-y
    By:
    • Chia-Chi Lin;
    • Beeram, Muralidhar;
    • Rowinsky, Eric K.;
    • Takimoto, Chris H.;
    • Ng, Chee M.;
    • Geyer Jr., Charles E.;
    • Denis, Louis J.;
    • De Bono, Johann S.;
    • Hao, Desiree;
    • Tolcher, Anthony W.;
    • Rha, Sun-Young;
    • Jolivet, Jacques;
    • Patnaik, Amita
    Publication type:
    Article
    3
    4

    Phase 1 Study of Molibresib (GSK525762), a Bromodomain and Extra-Terminal Domain Protein Inhibitor, in NUT Carcinoma and Other Solid Tumors.

    Published in:
    JNCI Cancer Spectrum, 2020, v. 4, n. 2, p. 1, doi. 10.1093/jncics/pkz093
    By:
    • Piha-Paul, Sarina A;
    • Hann, Christine L;
    • French, Christopher A;
    • Cousin, Sophie;
    • Braña, Irene;
    • Cassier, Phillippe A;
    • Moreno, Victor;
    • Bono, Johann S de;
    • Harward, Sara Duckworth;
    • Ferron-Brady, Geraldine;
    • Barbash, Olena;
    • Wyce, Anastasia;
    • Wu, Yuehui;
    • Horner, Thierry;
    • Annan, Meg;
    • Parr, Nigel J;
    • Prinjha, Rabinder K;
    • Carpenter, Christopher L;
    • Hilton, John;
    • Hong, David S
    Publication type:
    Article
    5

    Comparative Survival of Asian and White Metastatic Castration-Resistant Prostate Cancer Men Treated With Docetaxel.

    Published in:
    JNCI Cancer Spectrum, 2020, v. 4, n. 2, p. 1, doi. 10.1093/jncics/pkaa003
    By:
    • Halabi, Susan;
    • Dutta, Sandipan;
    • Tangen, Catherine M;
    • Rosenthal, Mark;
    • Petrylak, Daniel P;
    • Thompson, Ian M;
    • Chi, Kim N;
    • Bono, Johann S De;
    • Araujo, John C;
    • Logothetis, Christopher;
    • Eisenberger, Mario A;
    • Quinn, David I;
    • Fizazi, Karim;
    • Morris, Michael J;
    • Higano, Celestia S;
    • Tannock, Ian F;
    • Small, Eric J;
    • Kelly, William Kevin
    Publication type:
    Article
    6
    7

    Value of Early Circulating Tumor Cells Dynamics to Estimate Docetaxel Benefit in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients.

    Published in:
    Cancers, 2021, v. 13, n. 10, p. 2334, doi. 10.3390/cancers13102334
    By:
    • Lozano, Rebeca;
    • Lorente, David;
    • Aragon, Isabel M.;
    • Romero-Laorden, Nuria;
    • Nombela, Paz;
    • Mateo, Joaquim;
    • Reid, Alison H. M.;
    • Cendón, Ylenia;
    • Bianchini, Diletta;
    • Llacer, Casilda;
    • Sandhu, Shahneen K.;
    • Sharp, Adam;
    • Rescigno, Pasquale;
    • Garcés, Teresa;
    • Pacheco, Maria I.;
    • Flohr, Penelope;
    • Massard, Christophe;
    • López-Casas, Pedro P.;
    • Castro, Elena;
    • de Bono, Johann S.
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24

    Systematic study of tissue factor expression in solid tumors.

    Published in:
    Cancer Reports, 2023, v. 6, n. 2, p. 1, doi. 10.1002/cnr2.1699
    By:
    • de Bono, Johann S.;
    • Harris, Jeffrey R.;
    • Burm, Saskia M.;
    • Vanderstichele, Adriaan;
    • Houtkamp, Mischa A.;
    • Aarass, Saida;
    • Riisnaes, Ruth;
    • Figueiredo, Ines;
    • Nava Rodrigues, Daniel;
    • Christova, Rossitza;
    • Olbrecht, Siel;
    • Niessen, Hans W. M.;
    • Ruuls, Sigrid R.;
    • Schuurhuis, Danita H.;
    • Lammerts van Bueren, Jeroen J.;
    • Breij, Esther C. W.;
    • Vergote, Ignace
    Publication type:
    Article
    25

    Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5‐year follow‐up results from the STAMPEDE randomised trial (NCT00268476).

    Published in:
    International Journal of Cancer, 2022, v. 151, n. 3, p. 422, doi. 10.1002/ijc.34018
    By:
    • James, Nicholas D.;
    • Clarke, Noel W.;
    • Cook, Adrian;
    • Ali, Adnan;
    • Hoyle, Alex P.;
    • Attard, Gerhardt;
    • Brawley, Christopher D.;
    • Chowdhury, Simon;
    • Cross, William R.;
    • Dearnaley, David P.;
    • de Bono, Johann S.;
    • Diaz‐Montana, Carlos;
    • Gilbert, Duncan;
    • Gillessen, Silke;
    • Gilson, Clare;
    • Jones, Rob J.;
    • Langley, Ruth E.;
    • Malik, Zafar I.;
    • Matheson, David J.;
    • Millman, Robin
    Publication type:
    Article
    26

    Safety, pharmacokinetic, pharmacodynamic and clinical activity of molibresib for the treatment of nuclear protein of the testis carcinoma and other cancers: Results of a Phase I/II open‐label, dose escalation study.

    Published in:
    International Journal of Cancer, 2022, v. 150, n. 6, p. 993, doi. 10.1002/ijc.33861
    By:
    • Cousin, Sophie;
    • Blay, Jean‐Yves;
    • Garcia, Irene Braña;
    • de Bono, Johann S.;
    • Le Tourneau, Christophe;
    • Moreno, Victor;
    • Trigo, Jose;
    • Hann, Christine L.;
    • Azad, Arun A.;
    • Im, Seock‐Ah;
    • Cassier, Philippe A.;
    • French, Christopher A.;
    • Italiano, Antoine;
    • Keedy, Vicki L.;
    • Plummer, Ruth;
    • Sablin, Marie‐Paule;
    • Hemming, Matthew L.;
    • Ferron‐Brady, Geraldine;
    • Wyce, Anastasia;
    • Khaled, Ahmed
    Publication type:
    Article
    27
    28
    29
    30

    Clinical activity of CC‐90011, an oral, potent, and reversible LSD1 inhibitor, in advanced malignancies.

    Published in:
    Cancer (0008543X), 2022, v. 128, n. 17, p. 3185, doi. 10.1002/cncr.34366
    By:
    • Hollebecque, Antoine;
    • Salvagni, Stefania;
    • Plummer, Ruth;
    • Niccoli, Patricia;
    • Capdevila, Jaume;
    • Curigliano, Giuseppe;
    • Moreno, Victor;
    • de Braud, Filippo;
    • de Villambrosia, Sonia Gonzalez;
    • Martin‐Romano, Patricia;
    • Baudin, Eric;
    • Arias, Marina;
    • de Alvaro, Juan;
    • Parra‐Palau, Josep L.;
    • Sánchez‐Pérez, Tania;
    • Aronchik, Ida;
    • Filvaroff, Ellen H.;
    • Lamba, Manisha;
    • Nikolova, Zariana;
    • de Bono, Johann S.
    Publication type:
    Article
    31
    32
    33
    34
    35
    36

    Clinical validation of circulating GDF15/MIC‐1 as a marker of response to docetaxel and survival in men with metastatic castration‐resistant prostate cancer.

    Published in:
    Prostate, 2024, v. 84, n. 8, p. 747, doi. 10.1002/pros.24691
    By:
    • Mahon, Kate L.;
    • Sutherland, Sarah IM;
    • Lin, Hui Ming;
    • Stockler, Martin R.;
    • Gurney, Howard;
    • Mallesara, Girish;
    • Briscoe, Karen;
    • Marx, Gavin;
    • Higano, Celestia S.;
    • de Bono, Johann S.;
    • Chi, Kim N.;
    • Clark, Georgina;
    • Breit, Samuel N.;
    • Brown, David A.;
    • Horvath, Lisa G.
    Publication type:
    Article
    37
    38
    39

    27-hydroxycholesterol and DNA damage repair: implication in prostate cancer.

    Published in:
    Frontiers in Oncology, 2024, p. 01, doi. 10.3389/fonc.2023.1251297
    By:
    • Galvan, Gloria Cecilia;
    • Friedrich, Nadine A.;
    • Das, Sanjay;
    • Daniels, James P.;
    • Pollan, Sara;
    • Dambal, Shweta;
    • Suzuki, Ryusuke;
    • Sanders, Sergio E.;
    • Sungyong You;
    • Hisashi Tanaka;
    • Yeon-Joo Lee;
    • Wei Yuan;
    • de Bono, Johann S.;
    • Vasilevskaya, Irina;
    • Knudsen, Karen E.;
    • Freeman, Michael R.;
    • Freedland, Stephen J.
    Publication type:
    Article
    40

    Tumor clone dynamics in lethal prostate cancer.

    Published in:
    Science Translational Medicine, 2014, v. 6, n. 254, p. 1, doi. 10.1126/scitranslmed.3009448
    By:
    • Carreira, Suzanne;
    • Romanel, Alessandro;
    • Goodall, Jane;
    • Grist, Emily;
    • Ferraldeschi, Roberta;
    • Miranda, Susana;
    • Prandi, Davide;
    • Lorente, David;
    • Frenel, Jean-Sebastien;
    • Pezaro, Carmel;
    • Omlin, Aurelius;
    • Rodrigues, Daniel Nava;
    • Flohr, Penelope;
    • Tunariu, Nina;
    • de Bono, Johann S.;
    • Demichelis, Francesca;
    • Attard, Gerhardt
    Publication type:
    Article
    41

    Phase 1 trial of the oral AKT inhibitor MK-2206 plus carboplatin/paclitaxel, docetaxel, or erlotinib in patients with advanced solid tumors.

    Published in:
    Journal of Hematology & Oncology, 2014, v. 7, n. 1, p. 3, doi. 10.1186/1756-8722-7-1
    By:
    • Rhoda Molife, L.;
    • Li Yan;
    • Vitfell-Rasmussen, Joanna;
    • Zernhelt, Adriane M.;
    • Sullivan, Daniel M.;
    • Cassier, Philippe A.;
    • Eric Chen;
    • Biondo, Andrea;
    • Tetteh, Ernestina;
    • Siu, Lillian L.;
    • Patnaik, Amita;
    • Papadopoulos, Kyriakos P.;
    • De Bono, Johann S.;
    • Tolcher, Anthony W.;
    • Minton, Susan
    Publication type:
    Article
    42
    43
    44
    45
    46
    47

    Multi-Purpose Utility of Circulating Plasma DNA Testing in Patients with Advanced Cancers.

    Published in:
    PLoS ONE, 2012, v. 7, n. 11, p. 1, doi. 10.1371/journal.pone.0047020
    By:
    • Perkins, Geraldine;
    • Yap, Timothy A.;
    • Pope, Lorna;
    • Cassidy, Amy M.;
    • Dukes, Juliet P.;
    • Riisnaes, Ruth;
    • Massard, Christophe;
    • Cassier, Philippe A.;
    • Miranda, Susana;
    • Clark, Jeremy;
    • Denholm, Katie A.;
    • Thway, Khin;
    • De Castro, David Gonzalez;
    • Attard, Gerhardt;
    • Molife, L. Rhoda;
    • Kaye, Stan B.;
    • Banerji, Udai;
    • de Bono, Johann S.
    Publication type:
    Article
    48
    49

    Talazoparib, a Poly(ADP-ribose) Polymerase Inhibitor, for Metastatic Castration-resistant Prostate Cancer and DNA Damage Response Alterations: TALAPRO-1 Safety Analyses.

    Published in:
    Oncologist, 2022, v. 27, n. 10, p. e783, doi. 10.1093/oncolo/oyac172
    By:
    • Mehra, Niven;
    • Fizazi, Karim;
    • Bono, Johann S de;
    • Barthélémy, Philippe;
    • Dorff, Tanya;
    • Stirling, Adam;
    • Machiels, Jean-Pascal;
    • Bimbatti, Davide;
    • Kilari, Deepak;
    • Dumez, Herlinde;
    • Buttigliero, Consuelo;
    • Oort, Inge M van;
    • Castro, Elena;
    • Chen, Hsiang-Chun;
    • Santo, Nicola Di;
    • DeAnnuntis, Liza;
    • Healy, Cynthia G;
    • Scagliotti, Giorgio V
    Publication type:
    Article
    50

    Talazoparib, a Poly(ADP-ribose) Polymerase Inhibitor, for Metastatic Castration-resistant Prostate Cancer and DNA Damage Response Alterations: TALAPRO-1 Safety Analyses.

    Published in:
    Oncologist, 2022, v. 27, n. 9, p. e783, doi. 10.1093/oncolo/oyac172
    By:
    • Mehra, Niven;
    • Fizazi, Karim;
    • Bono, Johann S de;
    • Barthélémy, Philippe;
    • Dorff, Tanya;
    • Stirling, Adam;
    • Machiels, Jean-Pascal;
    • Bimbatti, Davide;
    • Kilari, Deepak;
    • Dumez, Herlinde;
    • Buttigliero, Consuelo;
    • Oort, Inge M van;
    • Castro, Elena;
    • Chen, Hsiang-Chun;
    • Santo, Nicola Di;
    • DeAnnuntis, Liza;
    • Healy, Cynthia G;
    • Scagliotti, Giorgio V
    Publication type:
    Article